Hereditary Disease Articles & Analysis
11 news found
Application of induced pluripotent technology allows to fabricate tissues in diseased states, e.g., hereditary cardiac diseases, cardiac fibrosis, cancer and orphan diseases. ...
Applying induced pluripotent stem cell (iPSC) technology, patient-cell derived 3D micro tissues exhibiting hereditary cardiac diseases are mass-produced in micro wells. The live-in-tissue analysisTM (LITATM), ahigh content phenotypic analyzer, quantifies treatment-induced changes in the tissue construct’s physiological function and the bio-molecular ...
TMAs, such as aHUS, are rare diseases primarily affecting the kidney. They are hard to diagnose using traditional methods as they present as a number of nonspecific symptoms, such as severe hypertension, acute kidney injury/failure in the context of mechanical anemia and thrombocytopenia. ...
He is tasked with driving SeqOne’s R&D strategy notably in the area of rare diseases and oncology through the use of machine learning and data science. ...
We were impressed by SeqOne’s ability to support the full range of genomic analysis requirements, from simple analyses of small gene panels to the entire genome in both cancer and inherited diseases. This means that we can offer a complete solution that addresses our customers’ ...
About CENTOGENE CENTOGENE engages in diagnosis and research around rare diseases transforming real-world clinical, genetic, and multiomic data to diagnose, understand, and treat rare diseases. Our goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using our extensive rare disease ...
The round, led by Omnes, Merieux Equity Partners, together with the Software Club and existing investors, Elaia and IRDI Capital Investissement, will enable SeqOne Genomics to accelerate its international sales and the development of new collaborative genomic analysis tools to facilitate communications between different disciplines in the medical team, in order to improve patient outcomes in ...
About SeqOne Genomics A company focused on developing state-of-the-art genomic analysis tools for clinical applications in the field of rare and hereditary diseases and oncology. About Global Diagnostic Solution Ltd. ...
Inherited genetic variants can predispose an individual to cancer. Hereditary Breast and Ovarian Cancer (HBOC) Syndrome, for example, is caused by pathogenic mutations in distinct genes such as BRCA1/2, MLH1, MSH6, PMS2, respectively. ...
CSL Behring considers grant proposals which relate to bleeding and platelet disorders, immune deficiencies, pulmonary disease and critical care. The submission deadline for the next round of grants is April 30, 2011. ...
$1 million to develop tools to better understand the role of mitochondrial dysfunction in neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease, which together afflict at least one out of every 50 Americans. These three diseases share the property that ...